Favorable response to gefitinib treatment of lung adenocarcinoma with coexisting germline and somatic epidermal growth factor receptor mutations. [electronic resource]
Producer: 20110103Description: e701-3 p. digitalISSN:- 1527-7755
- Adenocarcinoma -- drug therapy
- Aged
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Base Sequence
- Chemotherapy, Adjuvant -- methods
- Cholecystitis -- complications
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- DNA Mutational Analysis
- Female
- Gefitinib
- Genes, erbB-1
- Genetic Predisposition to Disease
- Humans
- Incidental Findings
- Lung Neoplasms -- drug therapy
- Mutation
- Neoplasm Staging
- Pedigree
- Pneumonectomy
- Quinazolines -- therapeutic use
- Reverse Transcriptase Polymerase Chain Reaction
- Vinblastine -- administration & dosage
- Vinorelbine
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.